Cardioprotection for Duchenne’s muscular dystrophy
- 1 May 1999
- journal article
- research article
- Published by Elsevier in American Heart Journal
- Vol. 137 (5) , 895-902
- https://doi.org/10.1016/s0002-8703(99)70414-x
Abstract
No abstract availableKeywords
This publication has 37 references indexed in Scilit:
- Comparison of atrial natriuretic peptide, B-type natriuretic peptide, and N-terminal proatrial natriuretic peptide as indicators of left ventricular systolic dysfunctionThe American Journal of Cardiology, 1996
- Early reduction of neurohumoral factors plays a key role in mediating the efficacy of β-blocker therapy for congestive heart failureAmerican Heart Journal, 1996
- Changing mortality in dilated cardiomyopathyHeart, 1994
- End of life care in Duchenne muscular dystrophyPediatric Neurology, 1993
- Evaluation of Myocardial Damage in Duchenne's Muscular Dystrophy with Thallium-201 Myocardial SPECT.Japanese Heart Journal, 1993
- Angiotensin-converting enzyme inhibitors and renal function in heart failureThe American Journal of Cardiology, 1992
- Cardiomyopathy and pulmonary emboli in terminal Duchenne's muscular dystrophyAmerican Heart Journal, 1990
- A comparative study of thallium-201 single-photon emission computed tomography and electrocardiography in duchenne and other types of muscular dystrophyThe American Journal of Cardiology, 1988
- Effects of Enalapril on Mortality in Severe Congestive Heart FailureNew England Journal of Medicine, 1987
- Plasma Norepinephrine as a Guide to Prognosis in Patients with Chronic Congestive Heart FailureNew England Journal of Medicine, 1984